BRAFV600E-Associated Gene Expression Profile: Early Changes in the Transcriptome, Based on a Transgenic Mouse Model of Papillary Thyroid Carcinoma

Regulation of ERBB3/HER3 signaling in cancer

(2015) Kalpana Mujoo et al.   Oncotarget

Monocyte to macrophage differentiation-associated (MMD) targeted by miR-140-5p regulates tumor growth in non-small cell lung cancer

(2014) Weina Li et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Integrated Genomic Characterization of Papillary Thyroid Carcinoma

(2014) Nishant Agrawal et al.   CELL

Cribriform-Morular Variant of Papillary Thyroid Carcinoma Displaying Poorly Differentiated Features

(2013) Tadao Nakazawa et al.   INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY

Association Between BRAF V600E Mutation and Mortality in Patients With Papillary Thyroid Cancer

(2013) Mingzhao Xing et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Thyrotropin Signaling Confers More Aggressive Features with Higher Genomic Instability on BRAFV600E-Induced Thyroid Tumors in a Mouse Model

(2013) Florence Orim et al.   THYROID

A High Percentage ofBRAFV600EAlleles in Papillary Thyroid Carcinoma Predicts a Poorer Outcome

(2012) Anna Guerra et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

mTOR Pathway Overactivation in BRAF Mutated Papillary Thyroid Carcinoma

(2012) Alexandra Faustino et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Mutationally Activated BRAFV600E Elicits Papillary Thyroid Cancer in the Adult Mouse

(2011) R.-P. Charles et al.   CANCER RESEARCH

Gene expression profile of human thyroid cancer in relation to its mutational status

(2011) Dagmara Rusinek et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY

Getting Around PLX4032: Studies Turn Up Unusual Mechanisms of Resistance to Melanoma Drug

(2011) R. S. Tuma   JNCI-Journal of the National Cancer Institute

Progression of BRAF-induced thyroid cancer is associated with epithelial–mesenchymal transition requiring concomitant MAP kinase and TGFβ signaling

(2011) J A Knauf et al.   ONCOGENE

Thyrotrophin receptor signaling dependence of Braf-induced thyroid tumor initiation in mice

(2011) A. T. Franco et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The type III inositol 1,4,5-trisphosphate receptor is associated with aggressiveness of colorectal carcinoma

(2010) Kazunori Shibao et al.   CELL CALCIUM

Aldehyde Dehydrogenase 3B1 (ALDH3B1): Immunohistochemical Tissue Distribution and Cellular-specific Localization in Normal and Cancerous Human Tissues

(2010) Satori A. Marchitti et al.   JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY

Hyperactivation of MEK–ERK1/2 signaling and resistance to apoptosis induced by the oncogenic B-RAF inhibitor, PLX4720, in mutant N-RAS melanoma cells

(2010) F M Kaplan et al.   ONCOGENE

B-RafV600E and thrombospondin-1 promote thyroid cancer progression

(2010) C. Nucera et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Beta-catenin Nuclear Labeling is a Common Feature of Sessile Serrated Adenomas and Correlates With Early Neoplastic Progression After BRAF Activation

(2009) Shinichi Yachida et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Novel Therapeutic Inhibitors of the c-Met Signaling Pathway in Cancer

(2009) J. P. Eder et al.   CLINICAL CANCER RESEARCH

Molecular characteristics of papillary thyroid carcinomas without BRAF mutation or RET/PTC rearrangement: relationship with clinico-pathological features

(2009) Stéphanie Durand et al.   ENDOCRINE-RELATED CANCER

The Cytological, Clinical, and Pathological Features of the Cribriform-Morular Variant of Papillary Thyroid Carcinoma and Mutation Analysis of CTNNB1 and BRAF Genes

(2009) Chan-Kwon Jung et al.   THYROID

The removal of multiplicative, systematic bias allows integration of breast cancer gene expression datasets – improving meta-analysis and prediction of prognosis

(2008) Andrew H Sims et al.   BMC Medical Genomics

Gene Expression Profiling of Papillary Thyroid Carcinoma Identifies Transcripts Correlated with BRAF Mutational Status and Lymph Node Metastasis

(2008) G. Oler et al.   CLINICAL CANCER RESEARCH

Association of the T1799A BRAF mutation with tumor extrathyroidal invasion, higher peripheral platelet counts, and over-expression of platelet-derived growth factor-B in papillary thyroid cancer

(2008) Y. Wang et al.   ENDOCRINE-RELATED CANCER